A detailed history of Ahrens Investment Partners LLC transactions in Organon & Co. stock. As of the latest transaction made, Ahrens Investment Partners LLC holds 13 shares of OGN stock, worth $199. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Holding current value
$199
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

BUY
$21.42 - $32.08 $278 - $417
13 New
13 $0
Q1 2022

Apr 28, 2022

SELL
$30.45 - $39.36 $3,075 - $3,975
-101 Reduced 62.35%
61 $2,000
Q4 2021

Jan 21, 2022

BUY
$28.67 - $37.13 $4,644 - $6,015
162 New
162 $5,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Ahrens Investment Partners LLC Portfolio

Follow Ahrens Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ahrens Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ahrens Investment Partners LLC with notifications on news.